RNA-directed gene therapy targeting shPromA/shCCR5 tested in chronic HIV infection model July 23, 2021
Addition of CF-296 to SOC leads to enhanced antibacterial activity against MSSA and MRSA isolates July 22, 2021
Antengene obtains HREC approval in Australia for phase I study of ATG-101 in solid tumors and NHL July 22, 2021
RSS